Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry Disease

Shire · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
fabry disease, replagal, enzyme replacement therapy, agalsidase alfa, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 827789
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.